ロード中...
Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
Chromogranin A, due to its primary expression throughout the neuroendocrine system, is a widely accepted biomarker for the assessment of neuro-endocrine tumors. It has been traditionally used in the management of patients with tumors of gastro-enteropancreatic origin. Lately, it has also been implic...
保存先:
| 出版年: | World J Methodol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5366937/ https://ncbi.nlm.nih.gov/pubmed/28396845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5662/wjm.v7.i1.9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|